Research highlights the cardiovascular benefits of bioactive compounds found in Mediterranean plants, suggesting that these ...

Heart attacks are a leading cause of death and disability in Europe, and their effects often extend beyond the initial event, leading to chronic heart failure.

Advances in cardiovascular pharmacology have significantly enhanced patient outcomes through a new wave of medications ranging from anticoagulants and antiplatelet agents to lipid-lowering drugs and ...

T UESDAY, Nov. 26, 2024 (HealthDay News) -- From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure ...

The UAB Division of Cardiovascular Disease is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive ...

have a heart attack or stroke following cancer treatment. However, the specific mechanisms behind this issue had until now remained unclear. To address this question, the research team explored at a ...

Prescription rates increased from 2021 to 2023, but high variance seen between hospitals in the rate of prescriptions. (HealthDay News) — From 2021 to 2023, there was an increase in prescription ...

However, the specific mechanisms ... for both cancer and heart disease, may make those with atherosclerosis even more vulnerable to the ill effects of checkpoint inhibitors, adds Giannarelli ...

The court has directed CAQM to expedite action against top police, government and civic agency officials in Delhi for violating its orders on implementing the ban on entry of heavy trucks into the ...

Congestive heart failure (CHF), sometimes ... pressure and body weight. SGLT-2 inhibitors can improve CHF symptoms and reduce CHF-related mortality risk. The exact mechanism of how these drugs ...

All that would be more than bad enough, but we face these threats gravely hobbled by the Biden administration’s failure — one might even say refusal — to respond adequately to this disease ...